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Natural  killer (NK) 1 cells are a  heterogeneous population  of lymphoid cells 
from an unimmunized host that are able to lyse certain tumor cells and virally 
infected cells through a mechanism unrestricted by the major histocompatibility 
complex (MHC).  Human lymphocytes with NK activity can be highly enriched 
in the low density fractions of discontinuous Percoll gradients (1). Morphological 
examination of this  low density population  demonstrates that  the majority of 
these cells are large granular  ]ymphocytes (LGL) (1).  Recently (2-5),  several 
murine monoclonal antibodies, including anti-Leu-11, B73.1, 3G8, and VEP 13, 
have been produced that react with essentially all human NK cells, but not T 
cells, B cells, or monocytes. Anti-Leu-11 and related mAb react with an antigen 
associated with the Fc receptor for IgG present on NK cells and neutrophils, and 
can specifically inhibit Fc receptor-mediated functions (2, 3, 5). 
Lymphoblasts  with  the  characteristics of NK  cells  have  been  identified  in 
mixed lymphocyte response cultures using autologous and ailogeneic stimulators 
(6-13). Recently (6), we have examined the phenotypic, functional, and morpho- 
logical characteristics of the  lymphoblasts generated in  a  mixed lymphocyte/ 
tumor cell response (MLTR) culture using peripheral blood mononuclear cells 
as responders and an allogeneic B cell line as the stimulator.  In these cultures, 
the predominant cell type was a CD3 + T  lymphoblast. Typically, only 5-15% of 
the total lymphoblasts expressed the NK cell-associated antigen, Leu-11. Anti- 
gen-specific cytotoxicity against the stimulating B cell line  was mediated by a 
typical  CD3 + cytotoxic T  lymphoblast.  In  contrast,  the  majority of the  cells 
mediating  non-MHC-restricted  cytotoxicity  against  the  NK-sensitive  tumor 
K562  expressed the Leu-11  antigen and lacked pan T  cell-associated markers 
(6). The Leu-11 + cells isolated from these MLTR cultures demonstrate enhanced 
cytotoxic activity  against  NK-sensitive  and  -insensitive  tumor  cells,  and  blast 
morphology; in addition, they express antigens associated with cellular activation, 
e.g., class II MHC antigens and transferrin receptor (6). Interferon and interleu- 
kin 2 (IL-2) efficiently enhance NK cell-mediated cytotoxicity (14-21), and cell 
t Abbreviations  used in this paper:  CRs,  complement receptor type 3; E/T, effector/target; FACS, 
fluorescence-activated cell sorter;  FITC, fluorescein isothiocyanate; IL-2, interleukin 2; LGL, large 
granular lymphocytes; mAb, monoclonal  antibody; MHC, major histocompatibility complex; MLTR, 
mixed lymphocyte/tumor response; NK, natural killer; PE, phycoerythrin;  PHA, phytohemaggluti- 
nin. 
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lines  with  NK  cell  characteristics  have  been  established  using  IL-2 as  growth 
factor (22-25).  Since interferons and  IL-2 are present in high concentration in 
mixed lymphocyte response (MLR) cultures, it seemed likely that activation of 
the Leu-11 + cells resulted from a  response to these soluble factors. However, it 
was unresolved whether  NK cells in the  MLTR could directly respond against 
the stimulator. 
In  the  present  experiments,  we  have  questioned  whether  NK  cells  can  be 
activated by direct stimulation with the NK-sensitive tumor cell line, K562. Using 
highly purified populations of NK (Leu-11 +) and T  (Leu-11-) lymphocytes, we 
observed that Leu-11 + cells were activated when cocultured with mitomycin C- 
treated  K562  cells.  This activation process resulted in proliferation, enhanced 
cytotoxic activity,  and  expression  of activation  antigens,  such  as  transferrin 
receptor and class II MHC antigens. The activation was a direct consequence of 
interactions  between  Leu-ll +  cells  and  K562.  Exogenous  growth  factors  or 
accessory cells were not required. Previously (2), we demonstrated that Leu-11 + 
lymphocytes could be divided into discrete subpopulations on the basis of Leu-7 
antigen expression. We now report that expression of the Leu-7 antigen can be 
induced in the Leu-7+l 1  + subset by activation with K562. In contrast, stimulation 
of the Leu-7+l 1  + cells with K562 did not affect the antigenic phenotype. These 
data  establish  a  developmental  relationship  between  the  Leu-7-11 ÷ and  Leu- 
7+11 + cells and are consistent with the possibility that Leu-7 is a  differentiation 
antigen that appears late in the development of NK cells. 
Materials and Methods 
Preparation  of Human  Peripheral  Blood  Leukocytes.  Human  peripheral  blood  from 
randomly chosen normal donors was obtained from the American Red Cross, San Jose, 
CA or the Stanford Blood Center, Palo Alto, CA. Mononuclear cells were isolated using 
Ficoll/Hypaque (Pharmacia Fine Chemicals, Piscataway, N  J) by standard methods. Cells 
were washed extensively in phosphate-buffered saline (0.1  M phosphate, pH 7.3). 
Enrichment of LGL.  Monocytes were depleted from the peripheral blood mononuclear 
cells by adherence to plastic tissue culture flasks (26). B lymphocytes and residual adherent 
cells were removed by passing the cells through nylon wool (26). Nylon wool-nonadherent 
cells were layered onto a cushion of 43.5% Percoll, centrifuged for 50 min at 300 g, and 
the low density fraction was harvested from the gradient interface. We have demonstrated 
(26), using this procedure, that essentially all lymphocytes with NK activity are contained 
in the low density fraction. Typically, ~30-60% of the low density lymphocytes expressed 
the  NK cell-associated antigen,  Leu-11,  whereas  ~40-70%  expressed the pan  T  cell 
antigen, CD3, depending on the individual donor. 
Monoclonal  Antibodies.  All antibodies were prepared by the Becton Dickinson Mono- 
clonal Center,  Inc.  Anti-Tac (IL-2 receptor) mAb was  generously provided by Dr.  T. 
Waldmann, National Institutes of Health (27). Anti-Leu-4 mAb recognizes the pan T  cell 
antigen CD3. Anti-Leu-11 reacts with an antigen (CD 16) associated with the Fc receptor 
for IgG present on essentially all NK cells and neutrophils (2,  5). Anti-Leu-2a and anti- 
Leu-3a react with the CD8 and CD4 antigens, respectively. Anti-Leu-7 reacts with a subset 
of NK cells (2, 28). Anti-Leu-15 reacts with an antigen associated with the complement 
receptor type 3 (CRy) (L. Lanier and G. Ross,  unpublished observation). Anti-Leu-M3 
reacts  with  an  antigen  exclusively present  on  monocytes. The  CD  nomenclature for 
human  differentiation antigens,  proposed  by the  International  Workshop on  Human 
Leukocyte Differentiation Antigens (29) and approved by the World Health Organization, 
will be used to describe the T  cell differentiation antigens discussed in this paper. 
Immunofluorescence  and Flow Cytometry.  Immunofluorescent staining procedures have 1466  DIFFERENTIATION  OF  HUMAN  NATURAL  KILLER  CELLS 
been described previously (2, 30).  Fluorochrome-conjugated, isotype-matched mAb that 
did not specifically react with human cells were used to control for nonspecific binding. 
Immunofluorescence was  measured  using  a  fluorescence-activated cell  sorter (FACS) 
(FACS 440; Becton Dickinson Immunocytometry Systems, Mountain View, CA). Methods 
of flow cytometry have been described in detail elsewhere (2, 30). 
Tumor  Cells.  All tumor cell lines  were obtained from the American Type Culture 
Collection, Rockville, MD and were tested monthly to ensure against mycoplasma contam- 
ination. 
In Vitro Stimulation  of Lymphocytes Subsets.  Lymphocytes were cocultured with mito- 
mycin C-treated (80 ~g/ml, 1 h) tumor cells in RPMI  1640 (Irvine Scientific, Santa Ana, 
CA) supplemented with 5% heat-inactivated horse serum (JR Scientific, Woodland, CA), 
1 mM glutamine (Gibco Laboratories, Grand Island, NY), and antibiotics (complete culture 
medium). Responder cells in complete culture medium (0.5-5 ×  106/ml) were mixed with 
stimulator cells (0.1-1.0 ×  106/ml)  to achieve a ratio of 5:1. Cells were placed into 96- 
well round-bottom or 24-well plastic tissue culture plates (Falcon Plastics,  Oxnard, CA). 
Lymphocytes (1  ×  106/ml) in complete culture medium were stimulated with phytohe- 
magglutinin (PHA-M) (Gibco Laboratories) at a concentration of 2% (wt/vol). Lymphocyte 
proliferation was  measured by incorporation of [~H]thymidine.  Cultures  were pulsed 
overnight with  1 uCi [gH]thymidine (Amersham Corp., Arlington Heights, IL), and the 
cells  harvested using a  PHD Celt Harvester (Cambridge Technology, Inc., Cambridge, 
MA). Samples were placed in vials containing Complete Counting Cocktail 3a20 (Research 
Products International Corp., Mt.  Prospect, IL) and the radioactivity determined using 
an LS 7800 liquid scintillation counter (Beckman Instruments, Inc., Fullerton, CA). The 
mean of triplicate samples was used for all statistical  evaluation. 
Cytotoxicity  Assays.  Tumor cells were labeled with 5~Cr and were used as targets in a 4- 
h radioisotope release cytotoxicity assay, as described previously (2). 
Morphology.  Cells were cytocentrifuged onto ethanol-cleaned glass slides.  The speci- 
mens were fixed in absolute methanol for 10 min, air dried, stained in a  10% aqueous 
solution of Giemsa for 10 min, and washed in distilled water. 
Results 
Stimulation of Leu-l l- and Leu-l l + Lymphocytes With K562.  Peripheral blood 
lymphocytes from randomly selected normal individuals, depleted of monocytes 
by adherence,  were stained  with  fluorescein isothiocyanate (FITC)-conjugated 
anti-Leu-11 a mAb. ~ 10-20% of the lymphocytes were antigen positive, depend- 
ing on the donor. Lymphocytes were sorted into Leu-11- and Leu-11 ÷ fractions 
using  a  FACS.  The  isolated  subpopulations,  >90%  pure  as  determined  by 
reanalysis,  were  cocultured  with  an  NK-sensitive  tumor  cell  line,  K562,  or  a 
relatively NK-insensitive  B  cell line,  CCRF-SB.  The stimulator  cell lines  were 
treated with mitomycin C to prevent cell division. Proliferation by the responder 
cells  was  measured  on  day  6  by  [3H]thymidine  incorporation.  Leu-ll +  cells 
significantly proliferated  in  response  to  coculture with  K562,  but  usually  not 
CCRF-SB  (Table I).  In contrast,  Leu-11- lymphocytes strongly proliferated in 
response to the B cell line CCRF-SB, but reacted only weakly against K562. This 
preferential activation of Leu-1 ! + cells against K562 was observed in all donors, 
although the magnitude of the response varied (Table I). Kinetic studies revealed 
that the proliferative response of both the T  lymphocytes against CCRF-SB and 
the NK cells against K562 peaked on day 5 of culture (Fig.  1). 
Cells  harvested  after  6  d  of coculture  with  K562  were  examined  by  flow 
cytometry for light scatter characteristics and expression of surface differentia- 
tion antigens. As shown in Fig. 2, lymphocytes that expressed the Leu-11 antigen 
before coculture with K562 retained Leu-11  expression after 6  d. Similarly, all PHILLIPS  AND  LANIER 
TABLE  I 
Proliferation of Leu-11 + and Leu-I I- Lymphocytes  Cocultured With K562 
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[SH]thymidine  Stimula- 
Exp.  Responder  Stimulator  incorporation  tion in- 
dex 
cpm 
1  Leu-11-  --  431  ±  109  -- 
Leu-11 +  --  321  ±  57  -- 
Leu-I 1-  K562  1,549 ±  312"  3.6 
Leu-11 ÷  K562  10,523 ±  814  32.8 
Leu-11-  CCRF-SB  5,844 ±  114  13.6 
Leu-11 ÷  CCRF-SB  143 ±  72  0 
Leu-ll-  --  580 ±  150  -- 
Leu-ll ÷  --  610 ±  56  -- 
Leu-ll-  K562  1,600 ±  200  2.7 
Leu-ll +  K562  16,120 ±  240  26.4 
Leu-ll-  --  820 ±  110  -- 
Leu-ll ÷  --  341  ±  120  -- 
Leu-ll-  K562  3,280 ±  260  4.0 
Leu-ll ÷  K562  6,138 ±  220  18.0 
Peripheral blood mononuclear celts were stained with F1TC anti-Leu-1 la mAb, 
then separated into Leu-11- and Leu-11 ÷ lymphocyte subpopulations using a 
FACS. Reanalysis of the sorted cells indicated >95% purity. Lymphocytes were 
cocultured  with  or  without  mitomycin C-treated  K562  or  CCRF-SB  tumor 
cells, as indicated.  The culture wells were  pulses overnight with  1 gCi  [~H]- 
thymidine and harvested after 6  d  culture. 
*  Background  thymidine incorporation  by  the  mitomycin C-treated  K562  or 
CCRF-SB tumor cells (tumor inactivation control) was subtracted from the raw 
counts to determine the specific incorporation  by the effector cell population. 
Stimulation index: (cpm with stimulator)/(cpm without stimulator). 
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FIGURE  1.  Kinetics  of  proliferative  response.  Peripheral  blood  mononuclear  cells  were 
stained with  FITC anti-Leu-1 la  mAb and separated into  Leu-11- and Leu-11 ÷ lymphocyte 
subpopulations using a  FACS.  Reanalysis indicated  >95%  purity.  >99%  of the sorted  cells 
were  lymphocytes by morphological criteria.  Leu-i 1- and Leu-11 ÷ lymphocytes were cocul- 
tured with  mitomycin C-treated  K562  (K562  MLR) or CCRF-SB (CCRF-SB  MLR) cells in 
96-welt microtiter plates. Cultures were pulsed overnight with  [3H]thymidine and harvested 
oil days 3, 5, and 7. The stimulation index is defined as: (cpm with stimulator)/(cpm without 
stimulator). LEU  11-  SORTED 
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FIGURE 2.  Blastogenesis and expression of activation antigens on  lymphocyte subsets co- 
cultured with K562.  Peripheral blood mononuclear cells were stained with FITC anti-Leu- 
1 la mAb and separated into Leu-11- and Leu-11 + lymphocyte subpopulations using a FACS. 
Reanalysis indicated >90% purity. >99% of the sorted cells were lymphocytes by morphological 
criteria. Leu-11- (left)  and Leu-11 + (right)  lymphocytes were cocuhured with mitomycin C- 
treated K562 in 24-well culture plates. After 6 d, cells were harvested and stained with: FITC 
IgG and PE IgG control antibodies; FITC anti-Leu-1 la and PE anti-Tac; or FITC anti-Leu- 
1 la and PE anti-HLA-DR. In the upper panels, histograms displaying the forward angle light 
scatter are  presented  (x  axis,  256  channels,  linear scale; y  axis,  relative number of cells). 
Forward angle light scatter measurements essentially reflect cell size for lymphoid cells (31). 
In the lower panels, correlated measurements of green (x axis, log scale) and red (y axis, log 
scale) fluorescence are displayed as two-dimensional contour plots (2, 30). Based on the control 
sample, the contour plots were divided into quadrants: I, cells with red fluorescence only; lI, 
ceils with green and red fluorescence; III, unstained cells; and IV, cells with green fluorescence 
6nly. The number of cells in each area was integrated and the percentage of the total cells was 
determined. In the control samples, <5% of the lymphocytes were nonspecifically stained (i.e., 
present in quadrants I, II, and IV). In the population of Leu-11- cells cocultured with K562 
(left),  <5%  expressed the Leu-11  antigen.  31.7%  of the cells were  Leu-11-,  DR  + and <5% 
were Leu-11-, Tac  +. In contrast, after stimulation of the Leu-11 + cells with K562, -85-90% 
of these cells expressed Leu-11 antigen and 25.9% coexpressed Leu-11 and DR antigen. <5% 
of the Leu-11 + lymphocytes coexpressed Leu-11 and Tac antigen. (It should be noted that the 
density of Leu-I 1 antigen decreases after activation and may lead to underestimation of the 
percentage of dimly stained Leu-11 + cells). 
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lymphocytes that lacked Leu-11  antigen before coculture with K562 were Leu- 
11- after 6 d. Thus, there was no evidence for acquisition or loss of this antigen 
as a  consequence of stimulation  with  K562.  A  proportion of the  Leu-11 + cells 
coexpressed  HLA-DR antigen  (25%  in  Fig.  2)  and  transferrin  receptor  (not 
shown) after coculture with  K562.  Before culture,  <1%  of Leu-11 ÷ cells coex- 
pressed HLA-DR or transferrin receptor, indicating that class II MHC antigens 
and transferrin  receptor were  induced as a  consequence of activation.  Further 
evidence  for  activation  of the  Leu-11 +  cells  was  obtained  by  examining  the 
forward angle  light  scatter  properties  of these  cells.  For  lymphoid cells,  light 
scatter is essentially proportional to cell size (31). In contrast to the Leu-11- cells 
that proliferated only weakly in response to coculture with K562, a  majority of 
the  Leu-11 + cells demonstrated  light scatter characteristics similar  to mitogen- 
activated lymphoblasts (Fig. 2). This was confirmed by microscopic examination. 
A majority of the K562-activated Leu-11 + cells were lymphoblasts with abundant 
cytoplasm and azurophilic granules (not shown).  IL-2 receptor-associated anti- 
gen, Tac, was not detected on these Leu-11 ÷ lymphoblasts (Fig. 2). Similar results 
were obtained in three independent experiments. 
A more extensive antigenic profile of the K562-activated Leu- 11 + lymphoblasts 
is  presented  in  Fig.  3.  A  proportion of the  Leu-11 + lymphoblasts coexpressed 
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FIGURE 3.  Antigenic  pbenotype of Leu-I 1  + lymphocytes  after coculture with K562. Purified 
Leu-1 l + lymphocytes were cocultured with mitomycin C-treated K562 cells, as described in 
Fig. 2 After 6 d, viable cells were recovered and stained with: FITC IgG and PE IgG control 
antibodies; FITC anti-Leu-7 and  PE anti-Leu-1  lc; FITC anti-Leu-1  la and  PE anti-Leu-2; 
FITC anti-Leu-1  la and  PE anti-Leu-4; FITC anti-Leu-I la and  PE anti-CR3(Leu-15); and 
FITC anti-Leu-1 la and PE anti-Leu-M3. Data are presented as described in Fig. 3. Quantita- 
tion of the results revealed: 43.7% Leu-ll+7+; 43.3% Leu-1  I+7-; <5% Leu-ll-7  +. 26.3% 
Leu-ll+2+;  56.8% Leu-11+2-; 8.6% Leu-11-2  +  . <5%  Leu-ll+4+;  83.5% Leu-11+4-; <5% 
Leu-11-4  +. 17.5% Leu-11+CRs+;  67.6% Leu-11+CR3-;  6.3% Leu-11-CRs  +. <5% Leu-1  l+M3+; 
85.3% Leu-1  l+M3-; <5%  Leu-1  l-M3  +. >95% of the cells in the IgG control sample were 
unstained (quadrant lII). 1470  DIFFERENTIATION  OF  HUMAN  NATURAL  KILLER  CELLS 
Leu-2 (CD8),  Leu-7, and Leu-15 (CR3 associated) antigens.  These antigens are 
expressed on subpopulations of resting  Leu-! 1 + ceils isolated from fresh blood 
(2,  32).  The only notable difference  between  the freshly isolated Leu-11 + cells 
and the activated Leu-11 + lymphoblasts was that the cell surface density of Leu- 
15 apparently decreases during culture. Similarly,  we observed that the density 
of Leu-11  antigen  decreases  after activation.  Leu-M3, an antigen expressed on 
most monocytes, and Leu-4 (CD3), an antigen associated with the T  cell antigen 
receptor  complex,  were  not detected  on  the  K562-activated  Leu-11 + lympho- 
blasts (Fig.  3). 
The cytotoxic activity of the Leu-11- and Leu-11 + cells was determined after 
coculture  with  or  without  mitomycin  C-treated  K562  cells  for  6  d.  Leu-11- 
lymphocytes  cocultured  with  K562  usually demonstrated  minimal  cytotoxicity 
against  K562  (Fig.  4),  although  low  levels  of  cytotoxicity  were  occasionally 
observed in some individuals. Lymphoblasts derived from cocultures of Leu-11 + 
lymphocytes and K562 were significantly more cytotoxic against K562 than Leu- 
11 + cells cultured for 6 d without K562 (Fig. 4). Moreover, the K562-activated 
Leu-I 1  + lymphoblasts were highly cytotoxic at low effector-to-target (E/T) ratios 
for a broad range of tumor cell targets,  including U937,  CEM,  HSB-2,  CCRF- 
SB, HUT-78, and K562. (Fig. 5). 
Stimulation  of Subsets  Identified  by  Expression  of the  Leu-7  and  Leu-ll  Anti- 
gens.  Peripheral  blood  lymphocytes  can  be  divided  into  at  least  four distinct 
subpopulations based on the expression of the Leu-7 and Leu-11 surface antigens; 
i.e.,  Leu-7-11 +,  Leu-7+l 1 +,  Leu-7+l 1-,  and  Leu-7-11-  (2).  Lymphocytes,  en- 
riched for LGL by centrifugation on Percoil gradients,  were stained with FITC 
anti-Leu-1 la and phycoerythrin (PE)-avidin/biotin anti-Leu-7. The four subpop- 
ulations were separated  using two-color FACS procedures and were cocuhured 
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FIGURE  4,  Cytotoxic activity of Leu- 11- and Leu- l 1 + lymphocytes after coculture with K562, 
Leu-11-  and Leu-11 + lymphocytes were cocultured with (MLTR/K562) or without (control) 
mitomycin C-treated  K562 cells, as described in Fig.  2. After 6  d,  viable cells were isolated 
and tested for cytotoxic activity against K562 and CCRF-SB in a  4  h radioisotope release assay. PHILLIPS  AND  LANIER  1471 
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FIGURE 5.  Cytotoxicity of activated Leu-] 1  + lymphocytes. Leu-11 ÷ lymphocytes were cocul- 
tured with mitomycin C-treated K562 cells for 6 d, as described in Fig. 2.  Viable cells were 
isolated and tested for cytotoxic activity against K562, CCRF-SB, U937, CEM, HUT-78, and 
HSB-2 tumor cell targets in a 4 h radioisotope release assay. Unstimulated Leu-11 + lymphocytes 
and Leu-I 1- lymphocytes did not lyse (<5%) any of these targets at comparable E/T ratios 
(not shown). 
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Proliferation of lymphocytes expressing the Leu-7 and/or Leu-11 antigens cocul- 
tured with K562.  Nylon wool-nonadherent peripheral blood lymphocytes, enriched for NK 
cells using Percoll (Materials and  Methods),  were stained  with  FITC anti-Leu-1 la and  PE- 
avidin/biotin antiLeu-7. The resulting four subsets were separated by two-color FACS sorting. 
Reanalysis of the isolated populations indicated that all subsets were >95%  pure. The cells 
were cocuhured  with or without mitomycin C-treated  K562  cells in 96-well round-bottom 
plates for 6 d. Cultures were pulsed overnight with 1 #Ci [SHlthymidine and harvested. 
with  mitornycin  C-treated  K562  cells.  After  6  d  of  culture,  proliferation  was 
measured  by [3H]thymidine  incorporation  (Fig. 6).  Both  the Leu-7+l  1 + and  Leu- 
7-1 1 +  proliferated  in  response  to  K562,  with  the  latter  population  consistently 1472  DIFFERENTIATION  OF  HUMAN NATURAL  KILLER CELLS 
demonstrating significantly higher  levels of proliferation (2-10-fold  higher in 
three  experiments,  depending on  the  donor).  The  Leu-7+l 1-  and  Leu-7-11- 
lymphocytes were weakly stimulated by K562, although significant proliferation 
was observed in some donors (e.g., Table II, experiment 2). The anti-Leu-7 and 
anti-Leu-11 antibodies were not mitogenic for these cell populations, as demon- 
strated  by  the  lack  of proliferation  in  the  cultures  without  K562  (Fig.  6). 
Furthermore, when Percoll gradient-enriched LGL were stained with anti-Leu- 
7 and anti-Leu-11 antibodies before cocuhured with mitomycin C-treated K562 
cells, the stimulation index was essentially identical to the response of LGL not 
stained with these antibodies. Therefore, it is unlikely that using these mAb for 
isolation of these subpopulations significantly influenced their response. 
Analysis of the cytotoxic activity of the subpopulations after culture with K562 
indicated that the  Leu-7-11 + and  Leu-7+l 1  + cells were  both potent cytotoxic 
effectors.  The  Leu-7-11-  and  Leu-7+l 1-  lymphocytes cocultured  with  K562 
demonstrated minimal cytotoxic activity against K562 (Fig. 7). Previously (2), we 
demonstrated that the anti-Leu-7 and anti-Leu-11  antibodies do not affect the 
cytotoxic function mediated by NK cells. 
With respect to antigenic phenotype, we consistently observed that a significant 
proportion (20-40% in three independent experiments, depending on the donor; 
37.7%  in  Fig.  8)  of the  Leu-7-11 + cells acquired  expression  of Leu-7 antigen 
after stimulation with  K562  (Fig.  8).  It is  unlikely that the appearance  of the 
Leu-7+l 1  + cells in the Leu-7-11 ÷ population after stimulation with K562 resulted 
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cocuhured with K562. Lymphocyte  subsets expressing the Leu-7 and/or Leu-11 antigens were 
isolated by two-color FACS sorting and cocuhured with mitomycin C-treated  K562 cells, as 
described in Fig. 6. After 6 d, the viable cells were harvested and tested for cytotoxic activity 
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FIGURE 8.  Antigenic profile of lymphocytes expressing the Leu-7 and/or Leu-11  antigens 
cocultured with K562. Lymphocyte subsets expressing the Leu-7 and/or Leu-11 antigens were 
isolated by two-color FACS cell sorting. Reanalysis of the purified populations are shown in 
the left panels (sorted day 0). All populations were >90% pure.  These cells were cocultured 
with mitomycin C-treated K562. After 6 d, the viable cells were recovered and stained with 
FITC anti-Leu-I la and PE-avidin/biotin anti-Leu-7. Data are presented as described in Fig. 
2. <5% of the cells in the Leu-7-11- population expressed the Leu-7 and/or Leu-I 1 antigen 
after coculture with K562.95% of the Leu-7+l 1  + cells coexpressed both antigens before and 
after stimulation with K562. In contrast, 37.7 % of the Leu-7-11 + cells demonstrated expression 
of Leu-7 after stimulation with K562. The small proportion of Leu-7-11- cells (14.9%) shown 
in the Leu-7+l 1- population after coculture with K562 was not observed in three subsequent 
experiments,  and  was  likely  explained  by  expansion  or  preferential  survival  of  the  5% 
contamination of this population with Leu-7-11- cells during the sort. 1474  DIFFERENTIATION  OF  HUMAN  NATURAL  KILLER  CELLS 
from outgrowth of contaminating Leu-7+l I + cells, since reanalysis immediately 
after the sort  indicated <1%  contamination with  Leu-7+ll + cells in  the Leu- 
7-11 + sorted fraction (Fig.  8).  Additionally, the growth rate of the Leu-7-11 + 
population was approximately twice that of the Leu-7+l 1  + population  (Fig.  6). 
The antigenic phenotype of the Leu-7+l 1  + cells was unaffected by stimulation 
with K562; i.e., both Leu-7 and Leu-11 antigens were retained on essentially all 
cells (95%). Similarly, the Leu-7+l 1- cells neither gained expression of the Leu- 
11 antigen nor lost expression of Leu-7 as a consequence of coculture with K562 
in three of four experiments (Fig. 8). Expression of the Leu-7 or Leu-11 antigens 
was not induced on cells in the Leu-7-11- population after K562 coculture (Fig. 
8).  Consistent  results in  the proliferation, cytotoxic, and antigenic phenotype 
assays were obtained in three experiments using blood from independent donors. 
The  lymphocyte subsets  defined by  Leu-7  and  Leu-11  antigen  expression, 
isolated to >95%  purity by two-color FACS sorting, were stained with Giemsa 
and  morphologically examined.  The  Leu-7-11 + and  Leu-7+ll + subsets  were 
homogeneous populations of typical LGL with prominent azurophilic granules 
(Fig. 9, A and C). After coculture with K562 for 6 d, the majority of cells in both 
subpopulations revealed primarily blast morphology, with abundant cytoplasm, 
numerous azurophilic granules, and large lobular euchromatic nuclei (Fig. 9, B 
and D). -10-20%  of the Leu-7-11 + and Leu-7+l 1  + cells cocuitured with K562 
displayed typical mitotic configurations (Fig. 9, B and D). 
The  Leu-7+l 1-  cells,  although  also  morphologically  LGL,  were  generally 
smaller in size and consistently contained fewer azurophilic granules than either 
the Leu-7+l 1  + or Leu-7-11 + cells (Fig. 9E). Leu-7-11- cells were, morphologi- 
cally, typical agranular small lymphocytes. After coculture with K562  for 6 d, 
the morphology of most  Leu-7+l 1- and  Leu-7-11-  cells remained essentially 
unchanged (Fig. 9, F and H). However, a small percentage (5-10%) of cells with 
blast morphology were observed. 
Inhibition  of Stimulation  by mAb.  To determine the role of IL-2 receptors in 
the activation of granular lymphocytes by K562, anti-Tac (IL-2) receptor mAb 
or an isotype-matched nonreactive control IgG antibody were added to cocultures 
of mitomycin C-treated K562 and lymphocyte subpopulations, isolated by two- 
color  cell  sorting  with  FITC  anti-Leu-lla  and  PE-avidin/biotin  anti-Leu-7. 
Results from two independent donors are presented in Table II. The proliferative 
response of the Leu-7-11 + against K562  was minimally inhibited (9%,  Exp.  1; 
6%, Exp. 2), whereas the response of the Leu-7+l 1  + was partially inhibited (17%, 
Exp.  1;  18%,  Exp. 2) by anti-Tac. In contrast, the mitogenic response of the T 
lymphocytes (Leu-7-11-) from both donors was completely inhibited (98%) by 
anti-Tac. Furthermore, the proliferation in the Leu-7-11-and Leu-7+l 1- cells 
against K562 in Exp. 2 also was completely inhibited by anti-Tac, suggesting that 
a different mechanism may be involved in the response of Leu-11- and Leu-11 + 
FIGURE 9.  Morphology of lymphocytes expressing the Leu-7 and/or Leu-11 antigens after 
coculture with K562. Lymphocytes subsets expressing the Leu-7 and/or Leu-11 antigens were 
isolated to >95% purity by two-color FACS cell sorting.  Immediately after sorting (A, C, E, 
and G) or after 6 d of coculture with mitomycin C-treated K562 (B, D, F, and H), Leu-7-11 + 
(A, B),  Leu-7÷l 1  + (C, D), Leu-7+l 1- (E, F), and Leu-7-11- (G, H) were stained with Giemsa 
and examined by light microscopy, x  4,500. 1475 1476  DIFFERENTIATION  OF  HUMAN  NATURAL  KILLER  CELLS 
TABLE  II 
Inhibition of Proliferation by mAb 
Stimula- 
Percent  Responder  Stimulator  Antibody  [3H]thymidine  tion in- 
inhibition  dex 
cpm 
Experiment 1 
Leu-7-11 +  None  None  200 -  120  --  -- 
Leu-7-11 ÷  K562  Control IgG  9,300 +  230*  46.5  -- 
Leu-7-11 ÷  K562  Anti-Tac  8,515 -  115  42.6  9% 
Leu-7+l 1  +  None  None  507 +  213  --  -- 
Leu-7+l 1  ÷  K562  Control IgG  7,500 -+  120  14.8  -- 
Leu-7+l 1  +  K562  Anti-Tac  6,318 -  198  12.5  17% 
Leu-7+l 1-  None  None  815 +  180  --  -- 
Leu-7+l 1-  K562  Control IgG  1,725 -  271  2.1  -- 
Leu-7+l 1-  K562  Anti-Tac  891  -  176  1.1  92% 
Leu-7-11-  N  None  1,600 +  223  --  -- 
Leu-7-11-  K5t~,  Control IgG  2,541  -  211  1.6  -- 
Leu-7-11-  K562  Anti-Tac  1,640 __+  142  1.0  96% 
Leu-7-11-  PHA  Control IgG  48,113 +  416  30.1  -- 
Leu-7-11-  PHA  Anti-Tac  1,988 +1  260  1.2  98% 
Experiment 2 
Leu-7-11 +  None  None  420 -+  162  --  -- 
Leu-7-11 ÷  K562  Control IgG  12,810 +  260  30.5  -- 
Leu-7-11 ÷  K562  Anti-Tac  11,989 -  191  28.5  6% 
Leu-7+l 1  t  None  None  342 +  200  --  -- 
Leu-7+l 1  ÷  K562  Control IgG  6,580 _  190  19.2  -- 
Leu-7+l 1  +  K562  Anti-Tac  5,420 +  240  15.8  18% 
Leu-7+l 1-  None  None  500 +  170  --  -- 
Leu-7+l 1-  K562  Control IgG  3,260 +  203  6.5  -- 
Leu-7+l 1-  K562  Anti-Tac  620 +  198  1.2  96% 
Leu-7-11-  None  None  921  +  260  --  -- 
Leu-7-11-  K562  Control IgG  6,824 --+- 211  7.4  -- 
Leu-7-11-  K562  Anti-Tac  1,231  -+ 210  1.3  95% 
Leu-7-11-  PHA  Control IgG  18,420 +  341  20  -- 
Leu-7-11-  PHA  Anti-Tac  1,332 -  240  1.4  98% 
Leu-7 and Leu-11 subpopulations isolated by FACS sorting, as described in Fig. 6, were stimulated 
by coculture with K562 or PHA.  Anti-Tac antibody and nonreactive IgG control antibodies were 
added to the cultures at a  final concentration of 150 #g/ml. Cultures were pulsed overnight with 
1 #Ci [3H]thymidine and were harvested on day 6. The stimulation index is defined in Table I. 
*  Background thymidine incorporation by the mitomycin C-treated K562 or CCRF-SB tumor cells 
(tumor inactivation control) was subtracted from  the raw counts to determine the specific incor- 
poration by the effector cell population. Percent inhibition is defined as:  100  ×  [(cpm with K562 
and control IgG -  cpm without stimulator and antibody) -  (cpm with K562 and anti-Tac -  cpm 
without stimulator or antibody)/(cpm with K562  and  control IgG -  cpm without stimulator or 
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cells against K562. As described previously (14), anti-Tac antibody did not inhibit 
the cytotoxic activity of NK cells. 
Discussion 
Leu-11 + lymphoblasts (6) were a  minor  population  in  MLTR cultures  using 
an allogeneic B cell line as the stimulator.  In general, allogeneic B cell lines are 
relatively insensitive to NK-mediated cytotoxicity. We questioned whether Leu- 
11 + cells could be preferentially stimulated if an NK-sensitive tumor cell line was 
used as the stimulator in an MLTR culture. Poros and Klein (33) have reported 
that coculture of peripheral blood mononuclear cells with an NK-sensitive tumor 
cell, K562, results in the preferential  activation of lymphoblasts that express Fc 
receptors and are highly cytotoxic for K562.  In contrast (33),  stimulation  with 
allogeneic peripheral  blood lymphocytes preferentially  stimulates typical  E  ro- 
sette-positive lymphoblasts that lack Fc receptor expression. We have confirmed 
these  observations  (34).  Coculture  of mitomycin  C-treated  K562  with  either 
unseparated  peripheral  blood  lymphocytes  or  Percoll  gradient-enriched  low 
density lymphocytes results in proliferation and activation of cells expressing the 
Leu-11 antigen,  but usually lacking pan T  cell antigens (34).  Depletion studies 
(34) with antibody and complement show that the peripheral blood precursor of 
the activated Leu-11 + cell expresses the Leu-11 antigen. The structure on K562 
responsible for activation of NK cells is unknown, but it is important to note that 
K562 lacks expression of both class I and II MHC antigens on the cell surface. 
We do not know if K562 cells stimulate  NK cells through  release of a  soluble 
product, but are exploring this possibility. 
An important unresolved issue was whether or not NK cells could be stimulated 
directly by coculturing purified Leu-11 + cells with K562. We have demonstrated 
that  it is possible to selectively stimulate Leu-11 + and Leu-11- responders with 
K562  and  CCRF-SB,  respectively.  Stimulation  of the  highly  purified  Leu-11 + 
cells  with  K562  resulted  in  blastogenesis,  enhanced  cytotoxicity against  NK- 
sensitive and -insensitive targets, and egpression of cell surface activation antigens 
(class II MHC antigens and transferrin  receptor) on a portion of the cells. The 
observation  that  Leu-11 + granular  lymphocytes were preferentially  stimulated 
by K562  implies  that  NK  cells can  demonstrate  specificity in  the  recognition 
process.  These  experiments  also suggest that  Leu-11 + cells may be capable of 
stimulation  and  proliferation  in  the  absence  of  T  lymphocytes,  exogeneous 
growth factors, or accessory cells. However, the possibility that a small number 
of contaminating  monocytes  (<1%)  or  T  lymphocytes  (<5%)  influenced  the 
response of the Leu-11 + lymphocytes against K562 cannot be excluded. We are 
currently  investigating  the  influence  of adding  monocytes and  T  cells  to  the 
cultures,  and  determining  the  range  of tumor  cell  lines  that  are  capable  of 
initiating activation. 
The relationship between NK cells and T  lymphocytes has been a controversial 
issue.  The arguments  range  from the view that cytotoxic T  cells "degenerate" 
into NK cells, to the idea that NK cells are primitive T  lymphocytes that do not 
require thymic processing. We have been unable to induced expression of Leu- 
I1  antigen  by coculturing  purified  T  (Leu-1 I-)  lymphocytes with  K562.  Al- 
though,  typically, there was little cytotoxic or proliferative activity in the  Leu- 1478  DIFFERENTIATION  OF  HUMAN NATURAL  KILLER CELLS 
11-  population  after stimulation with  K562,  we observed  significant levels of 
proliferation and cytotoxicity in some individuals. This is consistent with reports 
that some IL-2-dependent clones that express T  cell antigen receptor and CD3 
antigen, but lack Fc receptors (Leu-11), can lyse NK-sensitive tumors (22-25). 
By  contrast,  essentially all  Leu-ll +  cells  stimulated  by  coculture  with  K562 
retained expression  of Leu-11  antigen, were  highly cytotoxic for NK-sensitive 
and -insensitive tumor cells, and usually did not acquire expression of the pan T 
cell antigens, CD3. The relationship between the K562-reactive CD3 ÷ lympho- 
cytes and Leu-11 + lymphocytes is unknown. 
Within the LGL population there is considerable heterogeneity in expression 
of cell  surface  antigens  (2,  3,  28,  32,  34,  35).  Previously,  we  (2)  and  other 
investigators (36)  have demonstrated that four distinct subsets of lymphocytes 
can be defined by expression of the Leu-7 and/or Leu-11 antigens. These subsets 
were purified and cocultured with K562. One interpretation consistent with the 
data is  that  the  Leu-7  antigen appears  late  in  the differentiation of NK cells. 
This relationship is depicted in Fig. 10. In this model, the Leu-7-11 + cells, when 
activated  with  an  appropriate  signal  such  as  stimulation  with  K562,  rapidly 
proliferate,  regenerating  more cells  with  the  Leu-7-11 + phenotype and  some 
cells that acquire the Leu-7 antigen. Our experiments unequivocally demonstrate 
that Leu-7+l 1  + lymphocytes can arise from Leu-7-11 + precursors, and that there 
is a developmental relationship between these two phenotypically distinct subsets. 
Based on  the observation  that  Leu-7+l 1  + cells derived from peripheral  blood 
consistently demonstrate lower proliferative capacity than the Leu-7-11 ÷ cells, 
we conclude that these cells may represent an NK cell that is more mature and 
has less regenerative capacity than the Leu-7-11 ÷ cell. 
Abo and colleagues (36,  37) have proposed that the Leu-7 antigen is an early 
marker  of  NK  cell  differentiation  and  that  the  Leu-7+l 1-  population  may 
represent a  "pre-NK" cell. They have predicted that the Leu-7+l 1- cells acquire 
the Leu-11  antigen during maturation and that the Leu-7 antigen may be lost 
upon activation of the Leu-7+l 1  + subset (36). This interpretation is inconsistent 
with results from aliogeneic MLTR experiments (6) and our present study. We 
have been unable to induce significant NK ceil-mediated cytotoxic function or 
FIGURE 10.  A model for the differentiation of Leu-ll  + lymphocytes.  In this model, Leu- 
11 +7- lymphocytes  can be activated by an appropriate stimulus,  such as interaction with K562 
cells. As a consequence, a proportion of the cells acquire activation antigens (e.g., HLA-DR 
and transferrin receptor, TFR). During the activation process, Leu-7-11  ÷ proliferate, regen- 
erating more cells with this antigenic phenotype. Additionally, Leu-7 antigen is induced on a 
proportion of the lymphocytes  (20-40%). PHILLIPS  AND  LANIER  1479 
expression  of the  Leu-11  antigen  on  the  Leu-7+l 1- cells by stimulation  with 
K562 or recombinant I L-2 (14). Thus, the relationship of the Leu-7+ 11- granular 
lymphocytes  to  Leu-ll +  cytotoxic  NK  cells  is  unclear.  Another  substantial 
difference between Leu-7+l 1- and  Leu-11 + cells is that  the former all express 
the CD3 antigen  (2), a  glycoprotein associated with the T  cell antigen receptor 
complex (38, 39). At present, there is no direct experimental evidence that these 
Leu-7 +, CD3 + lymphocytes are developmentally related to the Leu-11 + lympho- 
cyte population. 
In  this  study,  we  also  investigated  whether  anti-Tac  (IL-2  receptor)  mAb 
influenced the activation and proliferation of Leu-11 + cells in response to K562. 
Of particular interest, anti-Tac only minimally inhibited the proliferation of Leu- 
7-11 + cells against K562 and only partially inhibited the response of Leu-7+l 1  + 
cells.  Furthermore,  anti-Tac  mAb  did  not  react  with  Leu-ll +  lymphoblasts 
stimulated  with  K562.  In contrast,  the  PHA-induced mitogenic  response of T 
(Leu-11-) cells from  the  same individual  and  the proliferative  response of the 
Leu-11- cells against K562 was completely inhibited by anti-Tac antibody. These 
data imply either that  IL-2 and the IL-2 receptor are not involved in Leu-11 + 
NK cell stimulation  with K562 or that  NK cells possess a  distinct IL-2 receptor 
that  cannot  be  regulated  by  antibodies  against  the  Tac  epitope.  The  latter 
possibility is  supported  by reports  that  anti-Tac  antibody  failed to  inhibit  the 
augmentation of NK activity by recombinant IL-2 (14, 20). We are investigating 
whether IL-2 is involved in the stimulation of Leu-11 + cells with K562. 
The  observation  that  Leu-11 + lymphocytes can  respond  directly to an  NK- 
sensitive tumor cell makes this assay an excellent model with which to study the 
function of NK cells. It should thus be possible to explore the heterogeneity in 
target cell recognition, surface structures involved in the activation process, and 
the pathway of differentiation. 
Summary 
A subpopulation of low density granular iymphocytes that express the natural 
killer  (NK)  cell-associated  Leu-11  antigen  (IgG  Fc receptor)  were  stimulated 
directly  by coculture  with  an  NK-sensitive  tumor  cell,  K562.  T  lymphocytes 
(Leu-11-) responded only weakly when cocultured with K562. The response of 
Leu-11 + cells apparently did not require exogeneous factors or accessory cells. 
The K562-activated cells retained  expression of Leu-11  antigen,  acquired acti- 
vation antigens, and were highly cytotoxic against NK-sensitive and -insensitive 
tumor  cells.  Anti-IL-2.  receptor  monoclonal  antibody  minimally  inhibited  the 
activation of Leu-11 + cells by K562, but completely inhibited the phytohemag- 
glutinin-induced  activation of the Leu-11- cells from the same individual.  Leu- 
11 + cells can  be divided  into  Leu-7-11 + and  Leu-7+l 1  + subpopulations  using 
anti-Leu-7  antibody.  These  subsets were separated  by two-color fluorescence- 
activated cell sorting and cocultured with K562. Proliferation by Leu-7-11 + cells 
was significantly greater than  by Leu-11+7 + cells.  Leu-7+l 1- granular  lympho- 
cytes and  T  lymphocytes (Leu-7-1 I-)  typically proliferated  only weakly when 
cocultured  with  K562.  A  proportion  of the  Leu-7-11 +  cells  acquired  Leu-7 
antigen after stimulation with K562, whereas the phenotype of Leu-7+l 1  +, Leu- 
7+11-,  and  Leu-7-11-  subsets  was  unaffected.  These  results  demonstrate  a 1480  DIFFERENTIATION OF  HUMAN  NATURAL  KILLER  CELLS 
developmental relationship between the Leu-7-11 + and Leu-7+l 1  + lymphocytes 
and  suggest  that  Leu-7  antigen  may  be  expressed  late  in  the  differentiation 
pathway of NK cells.  The  direct activation of highly purified  Leu-11 + cells by 
coculture with K562 provides an in vitro model with which to study the activation 
and maturation of human NK cells. 
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